AG
TEVA icon

AmeriFlex Group’s Teva Pharmaceuticals TEVA Stock Holding History

AmeriFlex Group’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.73K Hold
51
– – ﹤0.01% 1304
2026
Q1 		$1.54K Hold
51
– – ﹤0.01% 972
2025
Q4 		$1.59K Sell
51
-51
-50% -$1.26K ﹤0.01% 1011
2025
Q3 		$2.06K Sell
102
-216
-68% -$3.79K ﹤0.01% 974
2025
Q2 		$5.27K Buy
318
+267
+524% +$4.31K ﹤0.01% 821
2025
Q1 		$784 Hold
51
– – ﹤0.01% 1221
2024
Q4 		$904 Buy
+51
New +$928 ﹤0.01% 1106

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

AmeriFlex Group's TEVA Position: Q2 2026 in Review

AmeriFlex Group held its Teva Pharmaceuticals (TEVA) position steady in Q2 2026 at 51 shares worth $1.73K. The position accounts for ﹤0.01% of the portfolio, ranked #1304.

AmeriFlex Group first reported a position in TEVA in Q4 2024 and has held it in 7 quarters since. The position peaked at $5.27K in Q2 2025. 672 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • AmeriFlex Group held 51 shares of Teva Pharmaceuticals worth $1.73K as of Q2 2026.
  • AmeriFlex Group left its Teva Pharmaceuticals share count unchanged in Q2 2026.
  • Teva Pharmaceuticals made up ﹤0.01% of AmeriFlex Group's portfolio in Q2 2026, its #1304 holding.
  • AmeriFlex Group first reported a position in Teva Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • AmeriFlex Group's Teva Pharmaceuticals position peaked at $5.27K in Q2 2025.
  • 672 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on AmeriFlex Group's 13F filing for Q2 2026, filed 14 Aug 2026.